StockNews.AI
VTAK
StockNews.AI
216 days

Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC

1. VTAK announced its acquisition of PeriKard, improving its market position. 2. The transaction involves issuing restricted VTAK common stock for 100% of PeriKard.

M&A
-0.74%Current Return
VS
+1.62%S&P 500
$0.472801/15 08:06 AM EDTEvent Start
$0.469301/16 02:24 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Acquisitions often enhance growth potential, similar to VTAK's past performance after strategic deals.

How important is it?

Strategic acquisitions like this can lead to revenue growth and market share increase.

Why Long Term?

The foundational impact of acquisitions usually reflects over a longer timeframe as integration occurs.

Related Companies

VTAK
FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to acquire PeriKard, LLC., in a transaction involving the issuance of restricted VTAK common stock for 100% of the LLC interests in PeriKard.

Related News